CRSP DOWN: Risk-off crushes biotech | Ezbrisk
By: Ezbrisk
Published:
Anomaly score: -2.2907634340015055
Confidence: 0.55
Market summary
Risk-off crushes biotech
Ezbrisk assessment
Geopolitical stress and rising rates are punishing long-duration growth assets like gene editing stocks.
Verdict ID: 9a110e17-d39a-4119-84bc-6e1d849c5b70